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Abstract
Background—Failure of physiologic transformation of spiral arteries has been reported in 
preeclampsia, fetal growth restriction, fetal death, and spontaneous preterm labor with intact or 
ruptured membranes. Spiral arteries with failure of physiologic transformation are prone to 
develop atherosclerotic-like lesions of atherosis. There are striking parallels between preeclampsia 
and atherosclerotic disease, and between lesions of atherosis and atherosclerosis. Endothelial 
activation, identified by intercellular adhesion molecule-1 expression, is present in atherosclerotic-
like lesions of heart transplantation and considered a manifestation of rejection. Similarly, 
endothelial activation/dysfunction has been implicated in the pathophysiology of atherosclerosis 
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and preeclampsia. Intercellular adhesion molecule-1-overexpressing-activated endothelial cells are 
more resistant to trophoblast displacement than nonactivated endothelium and may contribute to 
shallow spiral artery trophoblastic invasion in obstetrical syndromes having failure of physiologic 
transformation.
Objective—To determine whether failure of spiral artery physiologic transformation was 
associated with activation of interstitial extravillous trophoblasts and/or spiral artery endothelium 
and presence of acute atherosis in the placental basal plate.
Study Design—A cross-sectional study of 123 placentas (19-42 weeks’ gestation) obtained from 
normal pregnancies (n = 22), preterm prelabor rupture of membranes (n = 26), preterm labor (n = 
23), preeclampsia (n = 27), intrauterine fetal death (n = 15), and small for gestational age (n = 10) 
was performed. Failure of spiral artery physiologic transformation and presence of cell activation 
was determined using immunohistochemistry of placental basal plates containing a median of 4 
(minimum: 1; maximum: 9) vessels per placenta. Endothelial/trophoblast cell activation was 
defined by the expression of intercellular adhesion molecule-1 (ICAM-1). Investigators examining 
microscopic sections were blinded to clinical diagnosis. Pairwise comparisons among placenta 
groups were performed with the Fisher’s exact and Wilcoxon rank sum tests using a Bonferroni-
adjusted level of significance (.025).
Results—87% (94/108) of placentas having spiral arteries with failure of physiologic 
transformation (actin-positive and cytokeratin-negative) in the basal plate, and 0% (0/15) of 
placentas having only spiral arteries with complete physiologic transformation (cytokeratin-
positive and actin-negative), had arterial endothelial and/or interstitial extravillous trophoblasts 
reactive with the ICAM-1 activation marker (P < .001). A significant correlation (R2 = 0.84) was 
found between expression of spiral artery endothelial and interstitial extravillous trophoblast 
ICAM-1 (P < .001) in activated placentas. Lesions of atherosis were found in 31.9% (30/94) of 
placentas with complete and/or partial failure of physiologic transformation of spiral arteries that 
were ICAM-1-positive, in none of the 14 placentas with failure of physiologic transformation that 
were ICAM-1-negative, and in none of the 15 placentas with complete spiral artery physiologic 
transformation without failure (P = .001). All placentas (30/30, 100%) with atherosis were 
identified in placentas having concomitant spiral artery endothelial and interstitial extravillous 
trophoblast activation.
Conclusion—Failure of spiral artery physiologic transformation in the placental basal plate is 
associated with interstitial extravillous trophoblast and arterial endothelial activation along with 
increased frequency of spiral artery atherosis. These findings may be used to improve the 
characterization of different disorders of the placental bed such as in refining the existing tools for 
the early prediction of risk for preterm, preeclamptic, and other abnormal pregnancies.
Keywords
acute atherosis; endothelial activation; failure of physiologic transformation; ICAM-1; placental 
basal plate; spiral arteries; trophoblast activation
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Introduction
Remodeling of the spiral arteries during gestation leads to substantial dilation of these 
vessels, which at the point of discharge into the intervillous space, attain a luminal diameter 
10 times larger than myometrial spiral arteries. This remodeling is associated with a 10-fold 
increase in blood supply to the fetoplacental unit in the third trimester compared to the non-
pregnant uterus. Spiral artery remodeling, which increases total uteroplacental blood flow 
from a baseline value of 20-50 mL/min to 450-800 mL/min in singleton pregnancies (as 
measured utilizing the diffusion equilibrium principle [most often nitrous oxide] or 
electromagnetic flow probes placed directly on the uterine artery), is considered key to 
accommodate the increased blood flow to the uteroplacental circulation in the third trimester 
[1–7]. Initially, physiologic transformation of the spiral arteries includes endothelial 
vacuolation and smooth muscle swelling [8–11], and it has been attributed in part to immune 
processes within the decidua [4,12–18]. Subsequently, trophoblasts invading the spiral 
arteries destroy the smooth muscle in the media, which is replaced by fibrinoid material 
[1,3,19–21].
Physiologic transformation of the spiral arteries is a normal process with the degree of 
transformation being greater in the center of the placental bed than in the periphery [21–23]. 
Full conversion of both decidual and myometrial segments of the approximately 100-120 
spiral arteries normally found in the placental bed into large, remodeled uteroplacental 
vessels is key for normal deep placentation [21,23]. Such deep placentation can be defective 
when remodeling of the junctional zone of the spiral arteries (arterial segments in the inner 
third of the myometrium and overlying endometrium) is absent or incomplete [21,24–26]. 
Insufficient physiologic transformation of the spiral arteries is associated with adverse 
pregnancy outcomes [3,21,27], including second-trimester spontaneous abortion [28–30], 
fetal death [30], abruptio placentae [31], preeclampsia [1,32–34], small for gestational age 
[32–35], preterm labor [36], preterm prelabor rupture of membranes [37,38], and maternal 
autoimmune diseases [39].
Failure of physiologic transformation of spiral arteries is seen in deep placentation disorders 
such as preeclampsia with or without intrauterine growth restriction, intrauterine growth 
restriction without preeclampsia, preterm labor and preterm prelabor rupture of membranes, 
abruptio placentae, and second-trimester abortion [21]. This failure is characterized by the 
absence of spiral artery trophoblastic invasion and remodeling [40]. Currently this condition 
can be identified only in placental bed biopsies because these specimens are required to 
demonstrate a defect of myometrial transformation [40]. However, physiologic 
transformation begins in the decidual segment of the spiral arteries during the first wave of 
trophoblast invasion. Therefore, failure of transformation of the spiral arteries in the decidual 
segment represents a more severe disorder than lack of transformation of the myometrial 
segment only. Abnormal transformation of the decidual portion of the spiral arteries can be 
detected by examining the placental basal plate [33–35,37,39,41–45]. This has practical 
implications because the basal plate of the placenta is available for examination in all cases 
while a placental bed biopsy requires a specialized procedure generally performed during a 
cesarean delivery. Immunohistochemistry [44] allows in-depth examination of the vessel 
wall through antigen detection of its different cellular components, which reduces the 
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subjectivity of using only conventional light microscopy for vessel recognition in the 
placental basal plate.
Arteries with failure of physiologic transformation of the spiral arteries (but not those with 
physiologic transformation) are prone to develop atherosis. Intravascular inflammation and 
abnormal lipid metabolism can interfere with endothelial cell function, and predispose to 
atherosclerosis in non-pregnant subjects [46–53]. Women with preeclampsia, the prototypic 
obstetrical complication characterized by failure of physiologic transformation of the spiral 
arteries [19,21,32,54–58] have evidence of intravascular inflammation [57,59–62] as well as 
changes in lipid metabolism [63–66], such as increased concentrations of triglycerides, and 
low-density lipoprotein, and decreases in low-density lipoprotein particle size and high-
density lipoprotein [67]. Macrophage infiltration of the intima and media is identified in 
both atherosis and the lesions found in transplant vasculopathy [6,43,44,58,68–70]. 
Therefore, there are striking parallels between preeclampsia and atherosclerosis, as well as 
the lesions of atherosis and those observed in patients with ischemic heart disease.
Endothelial activation, identified by the expression of intercellular adhesion molecule 
(ICAM)-1, is present in atherosclerotic-like lesions of heart transplantation [71–76], and is 
considered a manifestation of rejection. Similarly, endothelial activation/dysfunction has 
been implicated in the pathophysiology of atherosclerosis [77–79] and preeclampsia [80–
83]. Activated endothelial cells with overexpression of cell-surface ICAM-1 [84–86] are 
more resistant to trophoblast displacement than non-activated endothelial cells [87], and may 
contribute to shallow spiral artery trophoblastic invasion in obstetrical syndromes associated 
with failure of physiologic transformation of the spiral arteries.
The purpose of this study was to determine whether there was an association among: (1) 
failure of physiologic transformation of the spiral arteries in the placental basal plate; (2) 
endothelial and trophoblast activation; and (3) the presence of atherosis.
Materials and Methods
Study design
A cross-sectional study was performed on 123 placentas (19-42 weeks’ gestation) collected 
at Hutzel Women’s Hospital, the Detroit Medical Center, under protocols approved by the 
Wayne State University and Eunice Kennedy Shriver National Institute of Child Health and 
Human Development Institutional Review Boards, and the analyses were completed by 2015 
at CBL Partners for Life, Indianapolis, IN, and the California Medical Innovations Institute, 
San Diego, CA. Placentas were obtained from: normal pregnancies (n = 22), preterm 
prelabor rupture of membranes (n = 26), preterm labor (n = 23), preeclampsia (n = 27), 
intrauterine fetal death (n = 15), and small for gestational age (n = 10). Normal pregnancies 
were defined as those without medical/obstetrical complications and with birthweights 
adequate for gestational age (>10th percentile) at term (≥37 weeks of gestation). Seventeen 
babies were delivered vaginally and five by cesarean (none of the mothers or babies were 
infected). Preeclampsia was defined as new-onset hypertension >20 weeks of gestation 
(systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg on at least two 
occasions, 4 hours to 1 week apart), edema, and proteinuria (≥300 mg in a 24-hour urine 
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collection or one dipstick measurement of ≥2+). Infants with fetal growth restriction were 
considered small for gestational age if they were <10th percentile for weight for their 
gestational age. Pregnancies were considered preterm when the gestational age was <37 
weeks. Birthweight percentiles were calculated using nationwide US natality data [88]. 
Placentas from mothers with obesity (body mass index ≥30), known to be associated with a 
pro-inflammatory state [89], were not included in the study. All women provided written 
informed consent prior to the collection of placenta samples. The Institutional Review Board 
of the sponsoring institution approved collection and use of samples for research purposes.
Definitions
The terms used in this study follow accepted nomenclature [90]. Briefly, the placental bed is 
part of the decidua and adjoining myometrium that underlie the placenta and provide blood 
supply to the intervillous space. Extravillous trophoblasts are all trophoblasts (fetal-derived 
cells) located outside the placental villi. Interstitial extravillous trophoblasts are placental 
bed trophoblasts that have entered the decidual stroma but have not yet invaded the spiral 
artery walls. Extravillous trophoblasts invading spiral artery walls and replacing smooth 
muscle and endothelium are termed “intra-arterial trophoblasts.” Physiologic transformation 
of the spiral arteries was defined as the complete trophoblastic invasion of the spiral arteries, 
partial failure of physiologic transformation of the spiral arteries as the incomplete 
trophoblastic invasion of the arterial muscular wall, and failure of physiologic 
transformation of the spiral arteries as the complete absence of trophoblastic replacement of 
the arterial wall.
Placental specimens and immunohistochemistry
Placental samples (10×10×5 mm) from placental septa near the center of the basal plate [3.5 
(SD 0.6) per placenta] of 123 placentas obtained immediately after delivery were embedded 
in Tissue-Tek® optimum cutting temperature compound (Miles Inc., Elkhart, IN) and snap-
frozen in liquid nitrogen. Seven serial sections (a total of seven slides) from each basal plate 
sample were used for the evaluation of the single-, double-, and triple-antibody techniques 
performed. Sample slides having basal plate spiral arteries defined immunohistochemically 
were included in the study, and samples without any spiral artery were excluded. A triple-
antibody technique [44,73] with antibodies to α-smooth muscle actin to identify vascular 
smooth muscle cells, cytokeratin to identify extravillous trophoblasts and intra-arterial 
trophoblasts, and von Willebrand factor to identify endothelial cells was used to detect 
complete or partial failure of physiologic transformation and physiologic transformation of 
spiral arteries (median of 4 [minimum: 1; maximum: 9] vessels per placental basal plate). A 
triple-antibody immunohistochemistry with α-actin, cytokeratin, and ICAM-1 identified 
interstitial extravillous trophoblast and spiral artery endothelial cell activation [44,73,91].
Normal term placentas had cytokeratin-positive, α-actin-negative, and von Willebrand 
factor-positive uteroplacental arteries. Failure of physiologic transformation of the spiral 
arteries was characterized by cytokeratin-negative, α-actin-positive, and von Willebrand 
factor-positive spiral arteries. Spiral artery atherosis was cytokeratin-negative, α-actin-
positive, and von Willebrand factor-positive and showed the presence of CD68+ 
macrophages in the intimal area of the spiral arteries. Serial sections (5 μm each) from each 
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placental block were obtained for light microscopy (hematoxylin and eosin) and single, 
double, and triple immunohistochemistry. The use of immunohistochemistry allowed a clear 
identification of the spiral arteries in all slides from the different serial sections, 
demonstrating 100% reproducibility. The deposition of neutral triglycerides and other lipids 
were examined using oil-red O to confirm atherosis. Individuals examining microscopic 
sections (C.A.L., H.L.D.) were blinded to clinical diagnoses.
Statistical analysis
Continuous measures were summarized using median, minimum, and maximum, and 
categorical measures were summarized as frequency (percent). Demographic variables were 
compared using a Fisher’s exact test (for discrete measures) and the Kruskal-Wallis test (for 
continuous measures); these tests compared values for atherosis groups (atherosis versus no 
atherosis). Comparison of continuous measures for groups (atherosis versus no atherosis) 
were evaluated using the Wilcoxon rank sum test. We used analysis of variance to compare 
means from multiple groups. A Bonferroni-adjusted level of significance of ˂.025 was used 
to establish statistical significance for subsequent pairwise comparisons. Statistical analysis 
was performed by one of the authors (J.W.H).
Results
The various statuses of the spiral artery physiologic transformation in the placental basal 
plate were defined immunohistochemically as follows: physiologic transformation of the 
spiral arteries had complete muscular wall replacement by cytokeratin-positive trophoblasts 
that surrounded the endothelial lining of the vessels (Figure 1, A); spiral arteries with failure 
of physiologic transformation and atherosis maintained an actin-positive muscular wall, and 
cytokeratin-positive trophoblastic cells (interstitial extravillous trophoblasts) surrounded but 
did not invade the arterial walls (Figure 1, B). Spiral arteries with partial failure of 
physiologic transformation had a combination of smooth muscle cells and intra-arterial 
trophoblasts in the arterial walls (Figure 1, C). The immunohistochemical characteristics of 
the different statuses of spiral artery physiologic transformation and atherosis are 
summarized in Table 1.
Of the 123 placentas studied, 108 had spiral arteries with failure of physiologic 
transformation (Table 2): 79 had failure of physiologic transformation in all spiral arteries 
examined and 29 had both failure of physiologic transformation and physiologic 
transformation (Table 2). Fifteen placentas had complete spiral artery physiologic 
transformation without any failure of physiologic transformation (Table 2). Spiral arteries 
with partial failure of physiologic transformation (n = 36) had α-actin-positive cells in part 
of the arterial wall and cytokeratin-positive trophoblastic cells in the rest of the wall (Table 1 
and Figure 1, C). Partial failure of physiologic transformation of the spiral arteries in the 
basal plate was associated with failure of physiologic transformation (n = 22), physiologic 
transformation (n = 8), or both (n = 6).
Of the 108 placentas with failure of physiologic transformation of the spiral arteries in the 
basal plate, 100 (100/101, 99%) were from women with complicated pregnancies, and 8 
(8/22, 36.4%) from normal pregnancies (Table 2). Of the 15 placentas with complete 
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physiologic transformation of the spiral arteries and no failure, however, only 1 (1/101, 1%) 
was from a woman with an abnormal pregnancy, and 14 (14/22, 63.6%) were from women 
with normal pregnancies (Table 2). Placentas with only physiologic transformation of the 
spiral arteries (Table 2) were found mostly in normal pregnancies, and placentas having only 
failure of physiologic transformation of the spiral arteries (Table 2) were seen predominantly 
in abnormal pregnancies with preeclampsia, small for gestational age, intrauterine fetal 
death, preterm labor, and preterm prelabor rupture of membranes (Table 2).
Of placentas from abnormal pregnancies, 99% had spiral arteries with failure of physiologic 
transformation in the basal plate and only 1% of them had all spiral arteries with physiologic 
transformation (P < .001) (Table 2). Contrarily, most placentas (63.6%) from normal 
pregnancies had all spiral arteries with physiologic transformation, and a smaller percentage 
of them (36.4%) had spiral arteries with failure of physiologic transformation (P <.001). All 
groups of abnormal pregnancies had a similarly high proportion of placentas with failure of 
physiologic transformation in all spiral arteries, which was highest in pregnancies with small 
for gestational age (9/10, 90%), preeclampsia (22/27, 81.5%), and intrauterine fetal death 
(12/15, 80%), and lowest in preterm labor (16/23, 69.6%) (Table 2). The combination of 
both failure of physiologic transformation and physiologic transformation of the spiral 
arteries was more frequently identified in preterm labor. Physiologic transformation of the 
spiral arteries without any failure of physiologic transformation was found predominantly in 
normal pregnancies (Table 2). We performed quantitative studies and evaluated the 
percentage of arteries with different degrees of physiologic transformation in the basal plate 
of the placentas of the different groups and subgroups studied (Table 3). The percentage of 
arteries with physiologic transformation and failure of physiologic transformation was 
significantly different between groups, but no differences were found in the percentage of 
arteries with partial failure of physiologic transformation (Table 3). The highest percentage 
of arteries with failure of physiologic transformation was found in placentas from fetal death 
and preeclampsia; the highest percentage of partial failure of physiologic transformation was 
found in small-for-gestational-age babies; the highest percentage of arteries with physiologic 
transformation was found in normal pregnancies and preterm labor; and the lowest 
percentage of arteries with physiologic transformation was found in small-for-gestational-
age placentas (Table 3).
Of the 94 placentas with ICAM-1 expression in arterial endothelium and/or extravillous 
trophoblasts, all (94/94, 100%) were associated with failure of physiologic transformation 
(Figure 1, E, and Table 2), and none with physiologic transformation without failure (Figure 
1, D, and Table 2) (P <.001). A significant correlation (R2 = 0.84) was found between 
interstitial extravillous trophoblasts and spiral artery endothelial ICAM-1 expression (P < .
001). Spiral arteries with partial failure of physiologic transformation also showed 
endothelial ICAM-1 expression (Figure 1, F). A high proportion of spiral arteries with 
endothelial and/or extravillous trophoblasts that were ICAM-1-positive (Table 2) was 
observed in complicated pregnancies. The combination of both failure of physiologic 
transformation of the spiral arteries and physiologic transformation was associated with a 
lower proportion of endothelial and/or extravillous trophoblasts that were ICAM-1-positive 
(Table 2). The percentage of arteries with endothelial ICAM-1 was significantly different 
between groups, being higher in small for gestational age and lower in normal pregnancies 
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(Table 3). Interestingly, spiral arteries with physiologic transformation had fewer CD68+ 
macrophages surrounding extravillous trophoblasts (Figure 2, A) and spiral artery 
endothelium (Figure 2, C) than arteries with failure of physiologic transformation, which 
had increased number of CD68+ macrophages around smooth muscle cells of uninvaded 
arteries (Figure 2, B and D), suggesting that increased inflammation is associated with 
arterial endothelial and/or extravillous trophoblast activation.
Atherosis, akin to placental atherosclerosis (Figure 3A), developed only in placentas with 
failure of physiologic transformation of the spiral arteries, and all placentas with atherosis 
had a high proportion of failure of physiologic transformation (Table 2) and activation of 
interstitial extravillous trophoblasts and spiral artery endothelium. Atherosis was identified 
in preterm labor (n = 6), preterm prelabor rupture of membranes (n = 9), preeclampsia (n = 
7), small for gestational age (n = 3), intrauterine fetal death (n = 4), and normal (n = 1) 
placentas (Table 2). The percentage of arteries with atherosis lesions was significantly 
different between groups (P < .001); the highest percentage was found in small for 
gestational age and fetal death, and the lowest percentage in normal pregnancies and preterm 
labor (Table 3). Arteries with atherosis had numerous oil red O-positive cells, which were 
not observed in arteries with either physiologic transformation or failure of physiologic 
transformation without atherosis (Figure 3, B to D). Oil red O-positive cells were confirmed 
to be macrophages (Figure 3, G). Spiral arteries with atherosis were α-actin-positive (Figure 
3, E and H) and cytokeratin-negative (Figure 3, F), as defined in Table 1. Lesions of 
atherosis were observed in 30% (30/100) of placentas with failure of physiologic 
transformation of the spiral arteries (Table 2) and, as expected, in none of the placentas with 
physiologic transformation (P = .001). Furthermore, all placentas with atherosis had 
concomitant spiral artery endothelial and interstitial extravillous trophoblast activation. 
Arteries with failure of physiologic transformation that were ICAM-1-positive had a higher 
frequency of atherosis than placentas without endothelial activation (P < .001). Atherosis 
was found in 31.9% (30/94) of placentas positive for ICAM-1 on spiral artery endothelium 
and/or interstitial extravillous trophoblasts; in none of the 13 placentas with failure of 
physiologic transformation that were ICAM-1-negative; and as expected, in none of the 15 
placentas with complete physiologic transformation that were ICAM-1-negative (P = .04).
We subsequently performed a comparison among the immunohistochemically defined spiral 
artery phenotypes in the basal plate and the different groups of pregnancies studied, the 
status of spiral artery transformation, and the presence of arterial endothelial/trophoblast 
activation and atherosis (Table 4). As expected, abnormal pregnancies had a significantly 
increased proportion of spiral arteries actin-positive and cytokeratin-negative; arteries actin-
positive and cytokeratin-negative were characteristic of failure of physiologic 
transformation, and showed increased ICAM-1 expression and atherosis (Table 4). The 
clustered bar chart (Figure 4) shows a summary of the immunohistochemical characteristics 
of the spiral arteries in the basal plate of the different pregnancy conditions studied, i.e., 
normal and abnormal pregnancies, physiologic transformation, partial failure of physiologic 
transformation, failure of physiologic transformation, placental ICAM-1 expression, and 
atherosis.
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Principal findings of the study
First, failure of physiologic transformation of the spiral arteries in the placental basal plate 
had ICAM-1-positive interstitial extravillous trophoblasts. Second, placentas with failure of 
physiologic transformation of the spiral arteries and extravillous trophoblast activation had 
concomitant spiral artery ICAM-1-positive endothelium. Third, failure of physiologic 
transformation of the spiral arteries that were ICAM-1-positive had a higher frequency of 
atherosis than placentas without endothelial activation.
Activated extravillous trophoblasts found around spiral arteries with failure of physiologic 
transformation but not arteries with physiologic transformation suggests that the presence of 
ICAM-1-positive interstitial extravillous trophoblasts prevents the normal invasion of spiral 
arteries by those cells, possibly by enabling maternal immune cells to react against activated 
extravillous trophoblasts. Impaired trophoblast invasion has been associated with an 
increased number of macrophages around spiral arteries in preeclampsia [92] that could lead 
to increased trophoblast apoptosis [93] and impaired arterial invasion.
Placentas with failure of physiologic transformation of the spiral arteries and endothelial 
activation had a significantly (P < .001) higher frequency of atherosclerotic-like lesions of 
atherosis than placentas without activation, suggesting that endothelial activation is 
paramount in the development of the lesion. Multiple pathologic processes involving 
excessive decidual inflammation have been implicated in the genesis of atherosis [94–97]. 
Local factors may contribute to lack of trophoblast invasion and lipid deposition in spiral 
arteries [96]. Trophoblast migration may be suppressed by an abnormal immune interaction 
between maternal and fetal cells [96]. It is noteworthy that atherosis and vascular lesions in 
rejected kidney and heart transplants are histologically similar, suggesting that atherosis may 
be the result of immune dysregulation at the maternal-fetal interface [43]. In the decidua, 
invading trophoblasts can act as ligands for maternal uterine immune cells since trophoblasts 
bear paternal (foreign) HLA-C antigens that can be detected by receptors on those cells [98–
101]. Under normal circumstances, immune cells do not initiate a destructive response 
toward trophoblasts, but this response could be triggered in complicated pregnancies and 
explain impaired trophoblast invasion [100,102]. We have previously proposed [43] that 
atherosis could have an immune origin. This hypothesis has gained support, as recently 
reviewed by Staff et al [96]. An immunological mismatch between mother and fetus can lead 
to dysregulation of decidual immunity, promote local decidual inflammation, and predispose 
to atherosis.
Uteroplacental ischemia can lead to the production of anti-angiogenic factors [103–113], 
such as sFlt-1 (soluble fms-like tyrosine kinase-1) [114–117] and endoglin [69,118], which 
can induce endothelial dysfunction and predispose to preeclampsia or an anti-angiogenic 
state [57,119–129]. In addition, an excess production of trophoblast debris can result in 
exaggerated intravascular inflammation and endothelial cell dysfunction [130–134]. 
Preeclampsia is characterized by intravascular inflammation [59–62,135] and, similar to 
atherosclerosis [46,136,137], is marked by increased levels of circulating pro-inflammatory 
cytokines (such as interleukin-6 and tumor necrosis factor-α [138–143]), C-reactive protein 
Labarrere et al. Page 9
Am J Obstet Gynecol. Author manuscript; available in PMC 2018 April 03.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
[141,142,144–146], and markers of leukocyte activation [144,147]. Interestingly, pregnancy 
may constitute a metabolic/vascular “stress test,” uncovering a subclinical endothelial cell 
dysfunction that manifests later in life, in mothers affected with preeclampsia or an anti-
angiogenic state [148–151].
Several adverse pregnancy outcomes, such as preeclampsia [1,32–34], have characteristic 
disordered deep placentation [28–42]. Our findings provide an association between failure of 
physiologic transformation of the spiral arteries in the placental basal plate and activation of 
spiral artery endothelial cells and extravillous trophoblasts. By secreting both tumor necrosis 
factor-α and a tryptophan-depleting enzyme, excess macrophages in the placental bed of 
women with preeclampsia have been implicated in defective extravillous trophoblast spiral 
artery invasion [152]. More recently, tumor necrosis factor-α has been found to mediate fetal 
growth restriction during abnormal maternal inflammation [58]. Macrophages inhibit 
extravillous trophoblast invasion both passively, by being attracted by extravillous 
trophoblasts, and actively, by inducing peri-arterial extravillous trophoblast apoptosis [152]. 
Arterial ICAM-1 up-regulation could facilitate macrophage recruitment as shown in 
placental villitis of unknown etiology and massive chronic intervillositis [153,154]. Aberrant 
ICAM-1 expression has been described in cultured syncytiotrophoblasts pre-treated with 
both inflammatory cytokines, which also facilitate adhesion of monocytes to the 
syncytiotrophoblast [155]. Monocytes adhering to placental syncytiotrophoblasts can induce 
tumor necrosis factor-α-dependent apoptosis accompanied by focal trophoblast disruption 
[156]. Focal damage of the placenta could be a route for maternal leukocyte infiltration into 
the villi and a possible mechanism of villitis [156]. From our findings, we postulate that 
activated extravillous trophoblasts could facilitate trophoblast damage, inflammation, and 
subsequent inhibition of spiral artery transformation. Failure of physiologic transformation 
of the spiral arteries could result from ICAM-1-reactive spiral artery endothelial cells 
impeding the normal invasion [157], or ICAM-1-enhanced reactivity could be a consequence 
of failure of the physiologic transformation.
The rates of failure of physiologic transformation in our study are higher than those reported 
previously in women with different placental disorders [20,21,36–38,158]. The differences 
could be explained by the number of blocks obtained from the basal plate’s placental septa 
[21] included in our study (a mean of 3.5 blocks per placenta) and the use of triple-antibody 
immunohistochemistry. The use of a triple-antibody immunohistochemical technique allows 
the simultaneous identification of three cell types—smooth muscle cells, trophoblasts, and 
endothelium—which facilitates identification not only of the type of vessel but its 
predominant cell type phenotypic characteristics. The immunohistochemistry technique 
using cytokeratin, actin, and von Willebrand factor as markers of trophoblasts, smooth 
muscle cells, and endothelium, respectively, allows for a more precise identification of the 
degree of transformation, or the lack thereof, in each vessel. Interestingly, our data in the 
placental basal plate are supported by recent findings of a significantly higher frequency of 
acute atherosis lesions in the placental basal plate than in placental bed biopsies (both 
decidua and myometrial segments), considering that atherosis lesions only develop in spiral 
arteries with failure of trophoblastic invasion [159]. As we previously discussed [36], the 
reasons why some women with failure of physiologic transformation of the spiral arteries 
develop preeclampsia, whereas others develop preterm labor, are unknown, and the 
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possibility still exists that women with preterm labor would have developed preeclampsia if 
the pregnancy had continued longer. We previously proposed that pathology of the placental 
bed, primarily through ischemia and/or other mechanisms such as a maternal-fetal immune 
response, may lead to preeclampsia, small for gestational age, preterm labor with intact or 
ruptured membranes, abruptio placentae, and fetal death; and why a similar insult would 
result in different clinical phenotypes depends on genetic and environmental factors and time 
of onset, duration, and extent of the ischemic insult [160]. Korzeniewski et al [161] recently 
demonstrated that maternal plasma angiogenic index-1 concentration ratios seem to reflect 
the burden of uteroplacental vasculopathy indicated by histologic examination of the 
placenta, regardless of clinical diagnosis. The time order between changes in plasma 
angiogenic index-1 concentration ratios and placental features consistent with maternal 
vasculopathy, however, remains to be determined. The identification of the highest 
proportion of arteries with complete physiologic transformation in women with preterm 
labor with intact membranes and preterm prelabor rupture of membranes and the lowest 
proportion of transformed spiral arteries in small for gestational age in our study, suggests 
that the difference between differing pathologies is centered in the varying proportion of 
spiral arteries with physiologic transformation and failure of physiologic transformation. 
Examining more samples or perhaps the whole placental basal plate would help clarify 
quantitative differences of vessel transformation in different pregnancy disorders that could 
explain the differing outcomes. Indeed, the presence of failure of physiologic transformation 
in the placental basal plate in our study was associated with a significantly lower gestational 
age, suggesting that abnormal placentation and the vasculopathies associated with it could 
predispose to an early delivery. The identification of failure of spiral artery physiologic 
transformation in multiple pregnancy complications in general and not only in malperfusion 
pathologies of the placenta in particular, suggests that inflammation leading to cell activation 
may be the trigger for an abnormal placentation that expresses as different pathologies of 
pregnancy. Finally, the frequency of atherosis in our study was higher than the frequency 
recently described in a large population of placentas from normal and abnormal pregnancies 
[159,162]. We believe this is due to the high sensitivity of triple-antibody 
immunohistochemistry when compared with hematoxylin-eosin used to detect failure of 
physiologic transformation of the spiral arteries and placental atherosis [44].
In support of the central role played by trophoblast invasion, Kam et al [163] demonstrated 
that the physiological change in spiral arteries during pregnancy can only take place when 
interstitial trophoblasts are present. In further studies [36,38], frequent transformational 
failure was seen in the myometrial but not decidual spiral artery segments in preterm 
prelabor rupture of membranes, and increased transformational failure was seen in 
myometrial and decidual segments in preterm labor with intact membranes. The frequency 
of failure was higher in preeclampsia than in either preterm prelabor rupture of membranes 
or preterm labor with intact membranes. In this study, failure of physiologic transformation 
of the spiral arteries was highest in pregnancies with preeclampsia and lowest in preterm 
labor. The differences seen between the physiological responses of normal pregnancy and 
placental disorders may be only quantitative and not qualitative. Since the fetoplacental unit 
is a semi-allograft, normal pregnancy can be considered a challenge to the maternal immune 
system [164–169], and indeed, is a state of physiologic intravascular inflammation. We and 
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other investigators have reported excessive intravascular inflammation in preeclampsia [59–
62], intrauterine growth restriction [170,171], preterm labor [172], preterm prelabor rupture 
of membranes [173], and acute pyelonephritis [174]. An exaggerated intravascular 
inflammatory process can impair remodeling of the spiral arteries and lead to endothelial 
cell activation and atherosis.
A further point that needs to be emphasized is the role of endothelial disruption in 
physiologic transformation of the spiral arteries and atherosis in complicated pregnancies. 
Interestingly, atherosis lesions can show endothelial disruption [175], and it is tempting to 
postulate that such disruption is no more than the development of atherosis in arteries with 
partial failure of physiologic transformation. Although the study did not examine smooth 
muscle cells, partial failure of physiologic transformation of the spiral arteries was shown 
immunohistochemically by complementarity staining for endothelium and endovascular 
trophoblast in vessels of the placental bed [176]. Our findings demonstrated that both failure 
of physiologic transformation and partial failure of physiologic transformation of the spiral 
arteries showed endothelial activation, and interestingly, partial failure of physiologic 
transformation had intravascular trophoblasts (Figure 1), as found in arteries with 
endothelial disruption. Areas with intravascular trophoblast and absence of endothelium in 
partial failure of physiologic transformation of the spiral arteries would not show any 
expression of endothelial activation markers, as found in our study.
The nomenclature used to describe disorders of vascular remodeling in the spiral arteries can 
be confusing and, at times, misleading. Craven et al [10] viewed vascular changes as the 
beginning of physiologic change that occurs without trophoblast invasion, but others [163] 
adopted a more narrow view of physiological change—one that not only includes 
trophoblast invasion but is defined by it. Pijnenborg et al [19] suggested a new nomenclature 
replacing the term altogether with “trophoblast-associated remodeling.” We suggest the term 
“defective superficial placentation” to describe the failure of physiologic transformation of 
the spiral arteries in the placental basal plate during pregnancy. Although examination of the 
basal plate exclusively without availability of placental bed biopsies does not allow 
identification of defective deep placentation, the diagnosis of defective superficial 
placentation is also abnormal, because it suggests severe failure of physiologic 
transformation of the spiral arteries.
Although it is difficult to be certain regarding initial events during the placental development 
by examining third-trimester placentas, it is tempting to suggest what happens during early 
placentation based on our findings. The sequence of events is that trophoblasts first invade 
the superficial (or decidual) segment of the spiral arteries and, only later, the myometrial 
segment of the arteries. While the hallmark for disorders of deep placentation is failure of 
trophoblast invasion in the myometrial segment (which requires a placental bed biopsy), the 
fact that trophoblast has not invaded the decidual segment indicates that the process is more 
severe. This interpretation is indicative of failure of the first wave of spiral artery 
trophoblastic invasion [34]. Furthermore, the approach that we have proposed (examination 
of the basal plate of the placenta) has practical value, given that placental bed biopsies are 
rarely performed, and often require a cesarean delivery. In contrast, examination of the basal 
plate of the placenta can be undertaken in all placentas, whether the mode of delivery is 
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vaginal or cesarean [34]. The concept of defective superficial placentation may be used to 
improve the characterization of different disorders of the placental bed. It is possible that our 
data will be valuable in refining the existing tools for the evaluation of risk before pregnancy 
or in early gestation for the prediction of subsequent pregnancy outcome.
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Figure 1. Different statuses of spiral artery physiologic transformation and ICAM-1 expression
Complete physiologic transformation of spiral arteries: A, presence of endothelium (blue) 
and trophoblast cells (red) in vessel wall; and D, absence of endothelial intercellular 
adhesion molecule (ICAM)-1 expression (arrow) with ICAM-1-negative trophoblast cells 
(blue, arrowhead). Failure of physiologic transformation of spiral arteries: B, characterized 
by spiral arteries with presence of endothelium (blue, arrowhead) and smooth muscle cells 
(green, arrow) without arterial invasion of trophoblast cells (red) as seen in artery in center 
(blue linings on left and lower right of figure corresponding to neighboring veins); and E, 
presence of endothelial ICAM-1 (red, arrow) with trophoblast cells (blue, arrowhead). 
Partial physiologic transformation of spiral arteries: C, presence of endothelium (blue), 
trophoblast cells (red, arrow), and smooth muscle cells (green, arrow) in part of vessel; and 
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F, presence of endothelial ICAM-1 (red, arrow) with trophoblast cells (blue, arrowhead) and 
smooth muscle cells (green). Note presence of intra-arterial trophoblasts (yellow arrow) in 
partial physiologic transformation of spiral arteries. Scale represents 50 μm. Original 
magnification: ×640.
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Figure 2. Macrophages and spiral artery physiologic transformation
Complete physiologic transformation of spiral arteries: A and C, few CD68+ macrophages 
(red, arrows) around endovascular trophoblast cells (A, blue) and presence of endothelium 
(C, blue) in vessels with normal trophoblastic invasion. Failure of physiologic 
transformation of spiral arteries: B and D, numerous CD68+ macrophages (arrows) around 
vessels, with presence of endothelium (D, blue), absence of intra-arterial trophoblast cells 
(B, blue), and presence of smooth muscle cells (B and D, green) in spiral arteries. Scale 
represents 50 μm. Original magnification: ×640.
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Figure 3. Histochemical and immunohistochemical characteristics of atherosis
Atherosis lesion recognized with hematoxylin-eosin stain: A, note presence of foam cells 
(arrows) reactive with oil red O, as shown in D, confirming presence of lipids, which are B, 
not observed in vessels with normal trophoblastic invasion or C, absence of trophoblastic 
invasion also reacted with oil red O. Atherosis was observed in spiral arteries using triple-
antibody technique that showed arterial smooth muscle cells (E, green), trophoblast cells 
surrounding but not replacing vessel walls (F, blue), and presence of macrophages in 
vessel’s intima (G, red, arrow). H, These cell subtypes are clearly shown in combined 
photograph. Triple-antibody immunohistochemistry for smooth muscle (alpha-actin, E), 
trophoblasts (cytokeratin, F), macrophages (CD68, G), and their combination (H). Scale 
represents 50 mm. Original magnification: ×640. A, Hematoxylin-eosin and B to D, oil red 
O stains.
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Figure 4. Summary of immunohistochemical characteristics of spiral artery physiologic 
transformation in basal plate of different pregnancy conditions studied
Clustered bar chart showing summary of immunohistochemical characteristics of spiral 
arteries in basal plate of different pregnancy conditions studied.
*Data were obtained from na = 179 arteries from np = 123 placentas;
**Failure of physiologic transformation considers complete and partial failure;
¶Placentas intercellular adhesion molecule (ICAM)-1-positive include spiral artery 
endothelial and/or extravillous trophoblast reactivity;
§Atherosis was identified in preterm labor (np = 6), preterm premature rupture of 
membranes (np = 9), preeclampsia (np = 7), small for gestational age (np = 3), fetal death (np 
= 4), and normal pregnancies (np = 1).
na, number of arteries; np, number of placentas.
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Table 1
Immunohistochemical markers in spiral artery physiologic transformation and atherosis
Immunohistochemical characteristics Complete physiologic transformation Partial physiologic transformation Failure of 
physiologic 
transformation
Atherosis
Cytokeratin Positive Positive/negative Negative Negative
Smooth muscle α-actin Negative Positive/negative Positive Positive
Von Willebrand factor Positive Positive Positive Positive
ICAM-1, endothelial Negative Positive/negative Positive Positive
ICAM-1, interstitial extravillous 
trophoblast
Negative Positive/negative Positive Positive
ICAM-1, intercellular adhesion molecule-1.
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Table 4
Immunohistochemistry of spiral artery physiologic transformation in the different study groups
Characteristics
Spiral artery immunohistochemistry (np= 123)a
P-valueb
Spiral arteries 
cytokeratin-positive 
and actin-negative 
(na=43)
Spiral arteries 
cytokeratin-positive 
and actin-positive 
(na=36)
Spiral arteries 
actin-positive and 
cytokeratin-
negative (na=100)
Abnormal pregnancies (np=101)a 22 (21.8%) 29 (28.7%) 97 (96.0%) <0.001
 Preeclampsia (np= 27) 5 (18.5%) 7 (25.9%) 27 (100%)
 Small for gestational age (np= 10) 1 (10%) 4 (40%) 10 (100%)
 Fetal death (np= 15) 3 (20%) 4 (26.7%) 15 (100%)
 Preterm labor (np= 23) 7 (30.4%) 7 (30.4%) 20 (87%)
 Preterm prelabor rupture of membranes (np= 26) 6 (23.1%) 7 (26.9%) 25 (96.2%)
Normal pregnancies (np=22) 21 (95.5%) 7 (31.8) 3 (13.6%) <0.001
Physiologic transformation w/o failure of physiologic 
transformation (np=15)c
15 (100%) 0 (0%) 0 (0%)
Failure of physiologic transformation w/or w/o physiologic 
transformation (np=108)
28 (25.9%) 28 (25.9%) 98 (90.7%)
Failure of physiologic transformation w/physiologic 
transformation (np=28)
28 (100%) 14 (50%) 19 (67.9%)
Failure of physiologic transformation w/o physiologic 
transformation (np=80)
0 (0%) 24 (30%) 77 (96.3%)
Placentas ICAM-1-positive (np=94)d 21 (22.3%) 28 (29.8%) 88 (93.6%) <0.001
Placentas with atherosis (np=30)e 4 (13.3%) 10 (33.3%) 30 (100%) <0.001
a
Data were obtained from na=179 arteries from np=123 placentas.
b
P-values compare the listed characteristic for the groups with spiral arteries that are cytokeratin-positive and actin negative (na =43), cytokeratin-
positive and actin-positive (na =36), and cytokeratin-negative and actin-positive (na =100).
c
Failure of physiologic transformation considers complete and partial failure.
d
Placentas ICAM-1-positive include spiral artery endothelial and/or extravillous trophoblast reactivity.
eAtherosis was identified in preterm labor (np =6), preterm prelabor rupture of membranes (np =9), preeclampsia (np =7), small for gestational age 
(np =3), fetal death (np =4), and normal pregnancies (np =1).
ICAM-1: Intercellular adhesion molecule-1.
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